Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary Option Care Health Announces Financial Results for Fourth Quarter and Full Year 2020 and Provides Guidance for Full Year 2021
BANNOCKBURN, Ill. , March 11, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “ Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year
Toggle Summary Option Care Health Announces Financial Results for Fourth Quarter and Full Year 2019 and Announces Guidance for Full Year 2020
BANNOCKBURN, Ill. , March 05, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “ Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year
Toggle Summary Option Care Health and Amedisys to Combine Creating a Leading, Independent Platform for Home and Alternate Site Care
All-Stock Transaction Combines Highly Complementary Businesses Unlocking Significant Benefits for Patients, Providers, Payers, and Care Teams Increases Access to High Quality Care for Communities Across the U.S. through a Unique National Clinical Platform Comprehensive Capabilities Across Alternate
Toggle Summary Option Care Health Acquires Infinity Infusion Nursing, LLC
BANNOCKBURN, Ill. , Oct. 04, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“ Option Care Health”) (Nasdaq: OPCH), the largest independent provider of home and alternate site infusion services in the United States , announced today that it has acquired Infinity Infusion Nursing, LLC
Toggle Summary Option Care and BioScrip Complete Merger to Form Option Care Health
Largest Independent Home and Alternate Site Infusion Provider Establishes the Standard of Care Across the United States Through Its Clinical Leadership and Technology-Enabled Patient-Centered Model BANNOCKBURN, Ill. & DENVER --(BUSINESS WIRE)--Aug. 7, 2019-- Option Care Enterprises, Inc.
Toggle Summary Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend that BioScrip Stockholders Vote “FOR” the Transaction Proposals in Connection with the Proposed Merger with Option Care
DENVER , July 22, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip"), the largest independent national provider of infusion and home care management solutions, today announced that Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co.
Toggle Summary Leading Healthcare Services Organizations Collaborate to Provide Innovative COVID Therapy Access Model
BATON ROUGE, La. , and BANNOCKBURN, Ill. , Jan. 05, 2021 (GLOBE NEWSWIRE) -- Amedisys , Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, and Option Care Health Inc. (NASDAQ: OPCH), the nation’s largest independent home and alternate site infusion services provider,
Toggle Summary Key Members of BioScrip’s Leadership Team to Continue in Executive Roles with Combined Company Following Close of Option Care Merger
DENVER , June 13, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip"), the largest independent national provider of infusion and home care management solutions, today announced that key members of BioScrip’s leadership team will continue in executive roles with the combined company
Toggle Summary Introducing Naven Health, a Leader in Nationwide Infusion Nursing
BANNOCKBURN, Ill. , April 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health , Inc. (“Option Care Health”) (Nasdaq: OPCH) announces the formation of a nationwide home infusion nursing network and clinical platform that will operate as Naven Health, Inc. (“Naven Health”), focused on delivering
Toggle Summary BioScrip to Participate in Upcoming Investor Conferences
DENVER , May 21, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen M.